Compounds > valproic acid

valproic acid and leucine

valproic acid has been researched along with leucine in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (20.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Moritani, S; Takakuwa, S; Terasaki, T; Tsuji, A1
de Almeida, IT; Duran, M; Maya, M; Overmars, H; Selhorst, J; Silva, MF; van Gennip, AH; Wanders, RJ1
de Almeida, IT; Diogo, L; Duran, M; Garcia, P; IJlst, L; Luís, PB; Ruiter, JP; Silva, MF; Wanders, RJ1

Other Studies

5 other study(ies) available for valproic acid and leucine

ArticleYear
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells.
    The Journal of pharmacology and experimental therapeutics, 1991, Volume: 258, Issue:3

    Topics: 3-O-Methylglucose; 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Acetates; Acetic Acid; Amino Acids; Animals; Blood-Brain Barrier; Brain; Capillaries; Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone; Carboxylic Acids; Cattle; Cells, Cultured; Endothelium, Vascular; Hydrogen-Ion Concentration; Leucine; Methylglucosides; Salicylates; Salicylic Acid; Tritium; Valproic Acid

1991
Characterization of plasma acylcarnitines in patients under valproate monotherapy using ESI-MS/MS.
    Clinical biochemistry, 2001, Volume: 34, Issue:8

    Topics: Adolescent; Adult; Aged; Anticonvulsants; Carnitine; Female; Humans; Leucine; Male; Middle Aged; Mitochondrial Trifunctional Protein; Multienzyme Complexes; Spectrometry, Mass, Electrospray Ionization; Valerates; Valproic Acid

2001
Inhibition of 3-methylcrotonyl-CoA carboxylase explains the increased excretion of 3-hydroxyisovaleric acid in valproate-treated patients.
    Journal of inherited metabolic disease, 2012, Volume: 35, Issue:3

    Topics: Biotinidase; Carbon-Carbon Ligases; Case-Control Studies; Chromatography, High Pressure Liquid; Enzyme Inhibitors; Gas Chromatography-Mass Spectrometry; Humans; Inhibitory Concentration 50; Kinetics; Leucine; Liver; Metabolomics; Models, Chemical; Valerates; Valproic Acid

2012